Page last updated: 2024-08-21

quinazolines and 4-methyl-3-(2-(2-morpholinoethylamino)quinazolin-6-yl)-n-(3-(trifluoromethyl)phenyl)benzamide

quinazolines has been researched along with 4-methyl-3-(2-(2-morpholinoethylamino)quinazolin-6-yl)-n-(3-(trifluoromethyl)phenyl)benzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bemis, JE; Boucher, C; Buchanan, JL; Buckner, WH; Cee, VJ; Chai, L; Deak, HL; DiMauro, EF; Epstein, LF; Faust, T; Gallant, P; Geuns-Meyer, SD; Gore, A; Gu, Y; Henkle, B; Hodous, BL; Hsieh, F; Huang, X; Kim, JL; Lee, JH; Martin, MW; Masse, CE; McGowan, DC; Metz, D; Mohn, D; Morgenstern, KA; Newcomb, J; Nunes, JJ; Oliveira-dos-Santos, A; Patel, VF; Powers, D; Rose, PE; Schneider, S; Tomlinson, SA; Tudor, YY; Turci, SM; Welcher, AA; White, RD; Zhao, H; Zhu, L; Zhu, X	1

Studies

Bemis, JE; Boucher, C; Buchanan, JL; Buckner, WH; Cee, VJ; Chai, L; Deak, HL; DiMauro, EF; Epstein, LF; Faust, T; Gallant, P; Geuns-Meyer, SD; Gore, A; Gu, Y; Henkle, B; Hodous, BL; Hsieh, F; Huang, X; Kim, JL; Lee, JH; Martin, MW; Masse, CE; McGowan, DC; Metz, D; Mohn, D; Morgenstern, KA; Newcomb, J; Nunes, JJ; Oliveira-dos-Santos, A; Patel, VF; Powers, D; Rose, PE; Schneider, S; Tomlinson, SA; Tudor, YY; Turci, SM; Welcher, AA; White, RD; Zhao, H; Zhu, L; Zhu, X

Other Studies

1 other study(ies) available for quinazolines and 4-methyl-3-(2-(2-morpholinoethylamino)quinazolin-6-yl)-n-(3-(trifluoromethyl)phenyl)benzamide

Article	Year
Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity. Journal of medicinal chemistry, 2006, Sep-21, Volume: 49, Issue:19 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Biological Availability; Cell Proliferation; Cells, Cultured; Female; Humans; In Vitro Techniques; Interleukin-2; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Male; Mice; Mice, Inbred BALB C; Models, Molecular; Quinazolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; T-Lymphocytes; Tumor Necrosis Factor-alpha	2006

Article

Year

Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity.

Journal of medicinal chemistry, 2006, Sep-21, Volume: 49, Issue:19

Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Biological Availability; Cell Proliferation; Cells, Cultured; Female; Humans; In Vitro Techniques; Interleukin-2; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Male; Mice; Mice, Inbred BALB C; Models, Molecular; Quinazolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; T-Lymphocytes; Tumor Necrosis Factor-alpha

2006